Sold as Lusedra. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 1 application for Fospropofol Disodium (sold as Lusedra), first approved Dec 8, 2008, with 0 new uses approved and 0 published complete response letters.
| Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESSFospropofol Disodium · Tongji Hospital | Not applicable | Recruiting | Aug 26, 2026 |
| Fospropofol Disodium Versus Propofol for Patient Satisfaction in UreteroscopyAnesthesia for Urologic Endoscopic Surgery, Urinary Calculi · Shiyou Wei | Phase 4 | Not yet recruiting | Jun 22, 2026 |
| Correlating EEG Dynamics With Consciousness Alteration Under AnesthesiaAltered State of Consciousness, General Anesthetics · Huazhong University of Science and Technology | — | Recruiting | Feb 13, 2026 |
| Fospropofol Disodium ED95 for Elderly Spinal Anesthesia SedationLower Extremity Surgery · Ya-Qun Zhou | Phase 4 | Not yet recruiting | Jan 12, 2026 |
| Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical TrialDrug Safety · Hui Xu | Phase 4 | Recruiting | Aug 27, 2024 |
| Efficacy and Safety of Fospropofol for Same-day Bidirectional Endoscopy in Elderly PatientsElderly Patients · Shanghai 6th People's Hospital | Phase 4 | Not yet recruiting | Feb 9, 2024 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
